194 related articles for article (PubMed ID: 12570716)
1. In vitro and in vivo antitumor effects of bisphosphonates.
Clézardin P; Fournier P; Boissier S; Peyruchaud O
Curr Med Chem; 2003 Jan; 10(2):173-80. PubMed ID: 12570716
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
Green JR; Clézardin P
Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
[TBL] [Abstract][Full Text] [Related]
3. The antitumor potential of bisphosphonates.
Clézardin P
Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates in cancer therapy.
Green JR
Curr Opin Oncol; 2002 Nov; 14(6):609-15. PubMed ID: 12409650
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates: preclinical review.
Green JR
Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425
[TBL] [Abstract][Full Text] [Related]
6. [Bisphosphonates in oncology].
Soltau J; Medinger M; Unger C; Drevs J
Med Monatsschr Pharm; 2003 Dec; 26(12):411-7. PubMed ID: 14699777
[No Abstract] [Full Text] [Related]
7. Potential anticancer properties of bisphosphonates.
Neville-Webbe HL; Gnant M; Coleman RE
Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in cancer therapy.
Stresing V; Daubiné F; Benzaid I; Mönkkönen H; Clézardin P
Cancer Lett; 2007 Nov; 257(1):16-35. PubMed ID: 17697748
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
Clézardin P
Bull Cancer; 2010 Aug; 97(8):937-49. PubMed ID: 20595092
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
Clézardin P; Ebetino FH; Fournier PG
Cancer Res; 2005 Jun; 65(12):4971-4. PubMed ID: 15958534
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of bisphosphonates.
Green JR
Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
Clézardin P
Bone; 2011 Jan; 48(1):71-9. PubMed ID: 20655399
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.
Van Acker HH; Anguille S; Willemen Y; Smits EL; Van Tendeloo VF
Pharmacol Ther; 2016 Feb; 158():24-40. PubMed ID: 26617219
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor potential of bisphosphonates.
Green JR
Med Klin (Munich); 2000 Oct; 95 Suppl 2():23-8. PubMed ID: 11089384
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of bisphosphonates on breast cancer cells.
Senaratne SG; Colston KW
Breast Cancer Res; 2002; 4(1):18-23. PubMed ID: 11879555
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of bisphosphonates: promising preclinical evidence.
Guise TA
Cancer Treat Rev; 2008; 34 Suppl 1():S19-24. PubMed ID: 18486348
[TBL] [Abstract][Full Text] [Related]
17. Potential anticancer properties of bisphosphonates: insights from preclinical studies.
Clezardin P
Anticancer Agents Med Chem; 2012 Feb; 12(2):102-13. PubMed ID: 21864232
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates in preclinical bone oncology.
Clézardin P; Benzaïd I; Croucher PI
Bone; 2011 Jul; 49(1):66-70. PubMed ID: 21145441
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
Boissier S; Ferreras M; Peyruchaud O; Magnetto S; Ebetino FH; Colombel M; Delmas P; Delaissé JM; Clézardin P
Cancer Res; 2000 Jun; 60(11):2949-54. PubMed ID: 10850442
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate anticancer activity in multiple myeloma.
Terpos E
Anticancer Agents Med Chem; 2012 Feb; 12(2):123-8. PubMed ID: 21864228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
